Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Flavonoid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113956224B details novel hesperetin derivatives with enhanced bioavailability. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Novel one-pot synthesis of difluoromethylsulfurized flavonoids via patent CN110294730A. Reduces cost and simplifies supply chain for pharmaceutical intermediates.
Patent CN101570529B reveals a high-yield route for flavonoid dimers, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Novel synthetic route for apigenin-7-O-glucoside-4'-O-rhamnoside intermediates. Overcomes extraction limits with high purity, scalable process for API manufacturing.
Patent CN105218606B details a phenol-based route for scutellarin. Offers high purity and scalable manufacturing for cardiovascular drug intermediates.
Patent CN101759702A details a novel BTC-based synthesis for pyrazole-flavonoids, offering phosphorus-free manufacturing and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN118638088B enables green flavonoid production. Reduces toxicity and cost. Reliable supply chain for pharmaceutical intermediates.
Novel patent CN118638089B enables CO2-based flavonoid synthesis. Offers high yield, mild conditions, and supply chain advantages for pharmaceutical intermediates.
Patent CN106946831A reveals mild photocatalytic fluorination for high-purity flavonoid intermediates, offering substantial cost reduction and supply chain reliability.
Patent CN101186600B details a mild, non-phosphorus cyclization for flavonoids using BTC and DMF. This method offers high yields and reduced environmental impact for pharmaceutical manufacturing.
Novel photochemical SO2 insertion method for 3-methylsulfonyl thioflavonoids. Mild conditions, high yield, oxidant-free process ideal for cost-effective pharmaceutical intermediate manufacturing.
Patent CN117247370A enables room-temperature thioflavonoid synthesis using CO2. Offers cost reduction and scalable supply for pharmaceutical intermediate manufacturing.